Palliative benefit of external-beam radiation in the management of platinum refractory epithelial ovarian carcinoma Journal Article


Authors: Gelblum, D.; Mychalczak, B.; Almadrones, L.; Spriggs, D.; Barakat, R.
Article Title: Palliative benefit of external-beam radiation in the management of platinum refractory epithelial ovarian carcinoma
Abstract: In vitro studies and clinical experience have suggested that patients with platinum-refractory epithelial ovarian carcinoma exhibit cross- resistance to radiation. Salvage with radiation in these patients is rare. However, radiation is often utilized to palliate symptoms caused by these chemotherapy-resistant tumors. Forty-seven patients with platinum-refractory epithelial ovarian carcinoma were referred for palliative radiation and 33 (70%) were evaluable for response. One to four regimens of platinum-based chemotherapy (median 2.7) were given to each patient prior to radiation therapy. Of the 33 evaluable patients, 23 (69.7%) had a complete resolution of symptoms after radiation, 8 (24%) bad a partial resolution, and 2 were unassessable because of unrelated medical complications. The median duration of response was 11 months (range 1-86) and closely approximated their survival. Thirteen of 33 patients (39%) obtained relief of symptoms for greater than 12 months, with 10 of 33 (30%) having symptoms controlled for 6 to 12 months. In only 10 patients (30%) was the duration of palliation less than or equal to 6 months. Four patients required reirradiation to the same area for recurrence of their symptom. External-beam radiation therapy can provide effective and durable palliation of symptoms in platinum-refractory epithelial ovarian carcinoma patients.
Keywords: adult; clinical article; aged; aged, 80 and over; middle aged; survival rate; retrospective studies; salvage therapy; cisplatin; antineoplastic agents; cancer radiotherapy; combined modality therapy; cancer palliative therapy; palliative care; ovarian neoplasms; recurrence; cancer regression; carcinoma; ovary carcinoma; beam therapy; humans; human; female; priority journal; article
Journal Title: Gynecologic Oncology
Volume: 69
Issue: 1
ISSN: 0090-8258
Publisher: Elsevier Inc.  
Date Published: 1998-04-01
Start Page: 36
End Page: 41
Language: English
DOI: 10.1006/gyno.1998.4934
PUBMED: 9570996
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 12 December 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Richard R Barakat
    629 Barakat
  2. Daphna Y Gelblum
    228 Gelblum
  3. David R Spriggs
    325 Spriggs
  4. Lois Ann Cassidy
    72 Cassidy